NCOG-09. EFFICACY OF HER2-TARGETED ANTIBODY THERAPY IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A NATIONAL ANALYSIS

BACKGROUND: Breast cancer brain metastases (BCBM) commonly develop in human epidermal growth factor 2-positive (HER2+) breast cancer, but BCBM patients are underrepresented in clinical trials, leading to a lack of knowledge on the efficacy of HER2-targeted therapy in this population. METHODS: We ana...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Hulsbergen, Alexander, Broekman, Marike, Smith, Timothy, Aizer, Ayal A, Iorgulescu, Bryan
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2020
Ämnen:
Outcome Measures and Neuro-Cognitive Outcomes
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650964/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.548
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk